Our vision is to be the catalyst for groundbreaking advancements in drug development.
Luminari isn’t building another AI application for life sciences - we’re building the intelligence infrastructure that connects technology to the full complexity of drug and medical product development. That starts with people. Our team brings more than 100 years of combined experience across clinical development, regulatory affairs, biostatistics, medical devices, pharma, CRO operations, and AI engineering - domain expertise that’s built into the technology, not layered on top of it.
AI is the connective tissue. It links scientific, clinical, operational, and regulatory workflows that have always operated in silos, and it’s built for how development actually happens: distributed across sponsors, CROs, sites, regulators, and geographies.
It’s also human in the loop by design. AI augments scientific and clinical judgment, it doesn’t replace it - the system gets smarter as experts use it, while accountability stays with the people who understand the science and the patient.
Our mission is simple: save lives, by shortening the path from discovery to bedside.
We look forward to sharing our vision with you - Contact Us.
Powerhouse Front Bench.
20+ years of experience in Healthcare and life sciences.
Launched more than 35 products globally, across a variety of TA’s, including but not limited to Oncology, Neurology, Rare Disease and others.
Worked with PwC, CVS Health, BioSolutia/Caremetx, Parexel, Amgen and others.
Numerous Technology Implementation/ Digital Transformation, Operational Efficiency, and Innovative Product Development and Utilization.
Strategic Advisor – client advocate and relationship builder
Life sciences executive with over 22 years expertise in data analytics, RWD/RWE, clinical research, market access, leadership and strategic partnerships.
Proven success driving business opportunities, managing key alliances, and exceeding sales and growth targets.
Core strengths in clinical research, commercialization, real-world data/evidence, AI, business development, strategic planning, and sales cycle and pipeline management.
Chief Data Officer – in-house geek and technology maven
Executive Advisor l Information & Decision Scientist l Operations Management
Worked on over 100 new projects with entrepreneurs and companies across the globe in numerous industries, including manufacturing, health and medical, telecommunications, information technology.
Academic rank of Professor in the Managerial Economics & Decision Sciences and Operations Management department.
Executive advisor and Chief Learning Officer
Executive Advisor SFU Venture Labs, startup coach, Chief Learning Officer (CLO) and former IBM Executive, Chief Operating Officer, Associate Faculty member, and TED Talker, constantly looking for ways to accelerate opportunity.
Chuck focuses on Learning Strategies, AI, Blockchain, Web3, and Digital Transformation.
More than 30 years of R&D leadership across the pharmaceutical and biotechnology industries.
Has previously served as Head of R&D IT/CIO for MedImmune, AstraZeneca’s biologics division, and later led Data Science and AI for AstraZeneca.
Has held senior roles at Schrödinger, Accelrys, GlaxoSmithKline, and Merck & Co. His career began with undergraduate research at Penn State, followed by roles at Tektagen (Charles River Laboratories), the Pennsylvania State Police as a forensic scientist, and STC (Orasure) as an R&D scientist. He holds degrees in biochemistry and molecular biology from Pennsylvania State University and Lehigh University.
Clinical Development executive with 20+ years experience spanning AbbVie, Labcorp Drug Development, Covance, emerging biotechs, specialty CROs, and MedTech innovators. Proven track record advising organizations on clinical trial strategy, operational transformation, and healthcare innovation. Proven track record supporting the successful development and approval of six therapies and medical technologies.
Core expertise in AI-enabled clinical development, neurosciences, immunology, oncology, radiopharmaceuticals, feasibility intelligence, clinical operations, portfolio strategy, MedTech, and growth strategy.
Jeffrey Scott Yablon is a life sciences executive with more than 25 years of experience driving growth, strategic partnerships, and clinical development solutions across biotech, pharma, and CRO organizations. He has held senior leadership roles with TAP Pharmaceuticals, Icon PLC, Parexel, Cognizant Life Sciences, ArisGlobal, Frontage Laboratories and Jigsaw Clinical Research, where he served as President and CEO . Jeffrey now serves as a Champion for Luminari, helping organizations accelerate innovation through AI enabled clinical and regulatory intelligence.
Jake Knorr joins as Executive Relationship Officer, bringing more than 20 years of pharmaceutical, biotechnology, and life sciences leadership, with senior roles at Acadia Pharmaceuticals, Asymchem, Eisai, Neurelis, Novo Nordisk, and Organon spanning specialty pharma, neuroscience, rare disease, women's healthcare, and CDMO services. He has been instrumental in numerous product launches and lifecycle initiatives, with a track record of building senior-level industry relationships and shaping go-to-market strategy that translates scientific innovation into commercial adoption and growth.
